PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation
Authors
Keywords
Breast cancer, Atorvastatin, PBK/TOPK, Geranylgeranylation, YAP
Journal
Cancer Cell International
Volume 15, Issue 1, Pages 27
Publisher
Springer Nature
Online
2015-02-28
DOI
10.1186/s12935-015-0178-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma
- (2014) P.K. Singh et al. IMMUNOBIOLOGY
- Metabolic control of YAP and TAZ by the mevalonate pathway
- (2014) Giovanni Sorrentino et al. NATURE CELL BIOLOGY
- The Biology of YAP/TAZ: Hippo Signaling and Beyond
- (2014) Stefano Piccolo et al. PHYSIOLOGICAL REVIEWS
- The Hippo pathway: regulators and regulations
- (2013) F.-X. Yu et al. GENES & DEVELOPMENT
- Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility
- (2013) Z. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Statins and cancer: Current and future prospects
- (2012) Maja Osmak CANCER LETTERS
- Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
- (2012) Fa-Xing Yu et al. CELL
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
- (2012) William A. Freed-Pastor et al. CELL
- c-Myc and E2F1 drive PBK/TOPK expression in high-grade malignant lymphomas
- (2012) Fang Hu et al. LEUKEMIA RESEARCH
- Targeting tumor cell metabolism with statins
- (2012) J W Clendening et al. ONCOGENE
- The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
- (2012) J. M. Lamar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer
- (2011) Xiaodan Wang et al. EUROPEAN JOURNAL OF CANCER
- Simvastatin Prevents Skeletal Metastasis of Breast Cancer by an Antagonistic Interplay between p53 and CD44
- (2011) Chandi Charan Mandal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy
- (2011) Takumi Shiraishi et al. Journal of Translational Medicine
- The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
- (2011) Bin Zhao et al. NATURE CELL BIOLOGY
- TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer
- (2011) M-C Shih et al. ONCOGENE
- Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth
- (2010) Nayana Ghosh-Choudhury et al. CELLULAR SIGNALLING
- The Hippo Signaling Pathway in Development and Cancer
- (2010) Duojia Pan DEVELOPMENTAL CELL
- Critical roles of LGN/GPSM2 phosphorylation by PBK/TOPK in cell division of breast cancer cells
- (2010) Chikako Fukukawa et al. GENES CHROMOSOMES & CANCER
- PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21
- (2010) F Hu et al. ONCOGENE
- Targeting the Mevalonate Pathway for Improved Anticancer Therapy
- (2009) G. Fritz CURRENT CANCER DRUG TARGETS
- Context-Dependent Requirement for dE2F during Oncogenic Proliferation
- (2008) Brandon N. Nicolay et al. PLoS Genetics
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started